Centessa Pharmaceuticals (CNTA) P/E (2021 - 2026)
Centessa Pharmaceuticals (CNTA) P/E from May 28, 2021 to Jun 25, 2026. The TTM Centessa Pharmaceuticals (CNTA) P/E is -23.28. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Centessa Pharmaceuticals (CNTA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -23.28 | +32.48% |
| 2025 | -17.57 | +102.33% |
| 2024 | -8.69 | +79.56% |
| 2023 | -4.84 | +291.70% |
| 2022 | -1.23 | -28.16% |
| 2021 | -1.72 | N/A |
Comparison Centessa Pharmaceuticals (CNTA) P/E with competitors
Centessa Pharmaceuticals (CNTA) P/E is -23.28.